For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
10 - 14 Dec 2019
Henry B. Gonzalez Convention Center, San Antonio, United States of America
SABCS 2019: Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual b...
SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence
SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breas...
SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type
SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite eff...
SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negativ...
SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with H...
SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated w...
SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing...
SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast ...
SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete respo...
SABCS 2019: Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy...
SABCS 2019: Breast cancer preventive effects of anastrozole persist long after stopping treatment
SABCS 2019: Combining atezolizumab with neoadjuvant chemotherapy does not improve pathologic complet...
SABCS 2019: Addition of S-1 to post-operative endocrine therapy improves outcomes for patients with ...
SABCS 2019: New HER2 antibody-drug conjugate yielded promising clinical responses in breast cancer p...